SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:lup.lub.lu.se:7fd08be3-041e-4222-96c7-8638e41333f9"
 

Sökning: onr:"swepub:oai:lup.lub.lu.se:7fd08be3-041e-4222-96c7-8638e41333f9" > Variation in maturi...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004708naa a2200505 4500
001oai:lup.lub.lu.se:7fd08be3-041e-4222-96c7-8638e41333f9
003SwePub
008170823s2017 | |||||||||||000 ||eng|
024a https://lup.lub.lu.se/record/7fd08be3-041e-4222-96c7-8638e41333f92 URI
024a https://doi.org/10.1210/jc.2016-34292 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
100a Billings, Liana K.u Harvard Medical School,Massachusetts General Hospital,NorthShore University HealthSystem4 aut
2451 0a Variation in maturity-onset diabetes of the young genes influence response to interventions for diabetes prevention
264 c 2017-04-27
264 1b The Endocrine Society,c 2017
300 a 12 s.
520 a Context: Variation in genes that cause maturity-onset diabetes of the young (MODY) has been associated with diabetes incidence and glycemic traits. Objectives: This study aimed to determine whether genetic variation in MODY genes leads to differential responses to insulin-sensitizing interventions. Design and Setting: This was a secondary analysis of a multicenter, randomized clinical trial, the Diabetes Prevention Program (DPP), involving 27 US academic institutions. We genotyped 22 missense and 221 common variants in the MODY-causing genes in the participants in the DPP. Participants and Interventions: The study included 2806 genotyped DPP participants randomized to receive intensive lifestyle intervention (n = 935), metformin (n = 927), or placebo (n = 944). Main Outcome Measures: Association of MODY genetic variants with diabetes incidence at a median of 3 years and measures of 1-year β-Cell function, insulinogenic index, and oral disposition index. Analyses were stratified by treatment group for significant single-nucleotide polymorphism 3 treatment interaction (Pint, 0.05). Sequence kernel association tests examined the association between an aggregate of rare missense variants and insulinogenic traits. Results: After 1 year, the minor allele of rs3212185 (HNF4A) was associated with improved β-Cell function in the metformin and lifestyle groups but not the placebo group; the minor allele of rs6719578 (NEUROD1) was associated with an increase in insulin secretion in the metformin group but not in the placebo and lifestyle groups. Conclusions: These results provide evidence that genetic variation among MODY genes may influence response to insulin-sensitizing interventions.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng
700a Jablonski, Kathleen Au George Washington University4 aut
700a Warner, A. Sofiau Massachusetts General Hospital4 aut
700a Cheng, Yu Chienu NorthShore University HealthSystem,University of Chicago4 aut
700a McAteer, Jarred B.u Massachusetts General Hospital4 aut
700a Tipton, Laurau George Washington University4 aut
700a Shuldiner, Alan R.4 aut
700a Ehrmann, David Au University of Chicago4 aut
700a Manning, Alisa K.u Broad Institute,Harvard Medical School,Massachusetts General Hospital4 aut
700a Dabelea, Danau Colorado School of Public Health4 aut
700a Franks, Paul W.u Lund University,Lunds universitet,Genetisk och molekylär epidemiologi,Forskargrupper vid Lunds universitet,Genetic and Molecular Epidemiology,Lund University Research Groups4 aut0 (Swepub:lu)med-plf
700a Kahn, Steven Eu University of Washington4 aut
700a Pollin, Toni Iu University of Maryland, Baltimore4 aut
700a Knowler, William Cu National Institute of Diabetes and Digestive and Kidney Diseases4 aut
700a Altshuler, Davidu Harvard Medical School,Broad Institute4 aut
700a Florez, Jose C.u Massachusetts General Hospital,Harvard Medical School,George Washington University,Broad Institute4 aut
710a Harvard Medical Schoolb Massachusetts General Hospital4 org
710a Diabetes Prevention Program Research Group
773t Journal of Clinical Endocrinology and Metabolismd : The Endocrine Societyg 102:8, s. 2678-2689q 102:8<2678-2689x 0021-972Xx 1945-7197
856u http://dx.doi.org/10.1210/jc.2016-3429x freey FULLTEXT
856u https://academic.oup.com/jcem/article-pdf/102/8/2678/19452572/jc.2016-3429.pdf
8564 8u https://lup.lub.lu.se/record/7fd08be3-041e-4222-96c7-8638e41333f9
8564 8u https://doi.org/10.1210/jc.2016-3429

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy